Shanghai Pharmaceuticals

(OTC) SHPMY

Current Price$7.60

Market Cap$1.40B

Since IPO (2014)-19%

5 Year-17%

1 Year+16%

1 Month+0%

Shanghai Pharmaceuticals Financials at a Glance

Market Cap

$1.40B

Revenue (TTM)

CN¥287.69B

Net Income (TTM)

CN¥5.81B

EPS (TTM)

$1.10

P/E Ratio

6.92

Dividend

$0.29

Beta (Volatility)

0.16 (Low)

Dividend

$0.29

Beta (Volatility)

0.16 (Low)

Price

$7.60

Volume

Open

$7.60

Price

$7.60

Volume

Open

$7.60

Previous Close

$7.60

Daily Range

$7.60 - $7.60

52-Week Range

$6.83 - $8.32

Estimated Earnings Date

Apr 27, 2026

Dividend

$0.29

Beta (Volatility)

0.16 (Low)

Price

$7.60

Volume

Open

$7.60

Previous Close

$7.60

Daily Range

$7.60 - $7.60

52-Week Range

$6.83 - $8.32

Estimated Earnings Date

Apr 27, 2026

SHPMY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Shanghai Pharmaceuticals

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

49,608

CEO

Da Wei Liu

Website

www.sphchina.com

Headquarters

Shanghai, 200020, CN

SHPMY Financials

Key Financial Metrics (TTM)

Gross Margin

11%

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

10%

Return on Assets

Earnings Yield

14.45%

Dividend Yield

3.77%

Payout Ratio

26.74%

Stock Overview

Market Cap

$1.40B

Shares Outstanding

183.81M

Volume

Avg. Volume

0.766

Financials (TTM)

Gross Profit

CN¥30.42B

Operating Income

CN¥9.94B

EBITDA

CN¥14.37B

Operating Cash Flow

CN¥6.15B

Capital Expenditure

-CN¥2.33B

Free Cash Flow

CN¥3.83B

Cash & ST Invst.

CN¥43.08B

Total Debt

CN¥49.48B

Shanghai Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

CN¥75.26B

+6.4%

Gross Profit

CN¥8.09B

+11.5%

Gross Margin

10.75%

N/A

Market Cap

$1.40B

N/A

Market Cap/Employee

$28.28K

N/A

Employees

49,402

N/A

Net Income

CN¥1.42B

+6.4%

EBITDA

CN¥2.77B

-7.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

CN¥41.12B

-8.7%

Total Debt

CN¥51.42B

+0.8%

Accounts Receivable

CN¥96.78B

+6.0%

Inventory

CN¥41.68B

+10.2%

Long Term Debt

CN¥4.72B

-41.6%

Short Term Debt

CN¥46.70B

+8.8%

Return on Assets

2.47%

N/A

Return on Invested Capital

10.29%

N/A

Free Cash Flow

-CN¥1.70B

+42.2%

Operating Cash Flow

-CN¥1.01B

+54.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

DSRLFDiaSorin S.p.A.

DSRLFDiaSorin S.p.A.$84.10+0.00%

CNVVYConvaTec Group Plc

CNVVYConvaTec Group Plc$10.84+0.37%

GNGBYGetinge AB (publ)

GNGBYGetinge AB (publ)$20.88+3.73%

GZPHFGuangzhou Baiyunshan Pharmaceutical Holdings Company Limited

GZPHFGuangzhou Baiyunshan Pharmaceutical Holdings Company Limited$2.34+0.00%

SHTDYSinopharm Group Co. Ltd.

SHTDYSinopharm Group Co. Ltd.$10.78+0.37%

SKHHYSonic Healthcare Limited

SKHHYSonic Healthcare Limited$14.32-1.38%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

RKLBRocket Lab

RKLBRocket Lab$102.39-0.11%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ONDSOndas

ONDSOndas$9.33-0.05%

Questions About SHPMY

What is the current price of Shanghai Pharmaceuticals?

Shanghai Pharmaceuticals is trading at $7.60 per share.

What is the 52-week range for Shanghai Pharmaceuticals?

Over the past 52 weeks, Shanghai Pharmaceuticals has traded between $6.83 and $8.32.

How much debt does Shanghai Pharmaceuticals have?

As of the most recent reporting period, Shanghai Pharmaceuticals reported total debt of CN¥9.06B.

How much cash does Shanghai Pharmaceuticals have on hand?

Shanghai Pharmaceuticals reported CN¥4.52B in cash and cash equivalents in its most recent financial results.

What is Shanghai Pharmaceuticals’s dividend yield?

Shanghai Pharmaceuticals currently has a dividend yield of 3.77%.

Shanghai Pharmaceuticals

Shanghai Pharmaceuticals Financials at a Glance

SHPMY News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Shanghai Pharmaceuticals

SHPMY Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Shanghai Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SHPMY

What is the current price of Shanghai Pharmaceuticals?

What is the 52-week range for Shanghai Pharmaceuticals?

How much debt does Shanghai Pharmaceuticals have?

How much cash does Shanghai Pharmaceuticals have on hand?

What is Shanghai Pharmaceuticals’s dividend yield?

Premium Investing Services